3B3-PE38

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name3B3-PE38
Drug Alias NamePE38 immunotoxin (NCI)3B3-PE38
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV envelope protein gp120 modulators
TargetsHIV envelope protein gp120
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A